Latest News

Mecasermin treatment for Rett Syndrome is safe, well-tolerated

A Phase 1 clinical trial using mecasermin [recombinant human insulin-like growth factor 1 (IGF-1)] has been completed for Rett Syndrome research, showing proof-of-principle that treatments like IGF-1 which are based on the neurobiology of Rett syndrome, are possible.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Copyright Confusion Has 'Chilling' Effects in Online Creative Publishing

  • Human mind: Making sense through order

  • Amputee makes history controlling two modular prosthetic limbs

  • Scientists map out how childhood brain tumors relapse

  • Scheduling sleep: Three nighttime habits to improve rest

  • Ability to balance on one leg may reflect brain health, stroke risk

  • Being humble: Research shows E.B. White was right in Charlotte's Web

  • Outreach program gets cessation help to smokers of low socioeconomic status

  • Yoga has potential to reduce risk factors of cardiovascular disease

  • How does prostate cancer form? Parkinson's Link?

  •